rs16023

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The ENST00000360228.11(CACNA1A):​c.2975A>T​(p.Glu992Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.143 in 1,502,488 control chromosomes in the GnomAD database, including 15,900 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E992Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.13 ( 1408 hom., cov: 32)
Exomes 𝑓: 0.14 ( 14492 hom. )

Consequence

CACNA1A
ENST00000360228.11 missense

Scores

1
1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13O:1

Conservation

PhyloP100: 2.84
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CACNA1A. . Gene score misZ 5.7845 (greater than the threshold 3.09). Trascript score misZ 3.9354 (greater than threshold 3.09). GenCC has associacion of gene with benign paroxysmal torticollis of infancy, developmental and epileptic encephalopathy, 42, undetermined early-onset epileptic encephalopathy, episodic ataxia type 2, familial or sporadic hemiplegic migraine, spinocerebellar ataxia type 6, Lennox-Gastaut syndrome, migraine, familial hemiplegic, 1.
BP4
Computational evidence support a benign effect (MetaRNN=0.0017878115).
BP6
Variant 19-13298658-T-A is Benign according to our data. Variant chr19-13298658-T-A is described in ClinVar as [Benign]. Clinvar id is 68427.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-13298658-T-A is described in Lovd as [Benign]. Variant chr19-13298658-T-A is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.148 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CACNA1ANM_001127222.2 linkuse as main transcriptc.2975A>T p.Glu992Val missense_variant 19/47 ENST00000360228.11 NP_001120694.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CACNA1AENST00000360228.11 linkuse as main transcriptc.2975A>T p.Glu992Val missense_variant 19/471 NM_001127222.2 ENSP00000353362 O00555-8

Frequencies

GnomAD3 genomes
AF:
0.134
AC:
20277
AN:
151782
Hom.:
1410
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.105
Gnomad AMI
AF:
0.163
Gnomad AMR
AF:
0.141
Gnomad ASJ
AF:
0.161
Gnomad EAS
AF:
0.123
Gnomad SAS
AF:
0.120
Gnomad FIN
AF:
0.123
Gnomad MID
AF:
0.182
Gnomad NFE
AF:
0.151
Gnomad OTH
AF:
0.149
GnomAD3 exomes
AF:
0.137
AC:
14100
AN:
102910
Hom.:
1026
AF XY:
0.134
AC XY:
7629
AN XY:
57098
show subpopulations
Gnomad AFR exome
AF:
0.112
Gnomad AMR exome
AF:
0.146
Gnomad ASJ exome
AF:
0.164
Gnomad EAS exome
AF:
0.0934
Gnomad SAS exome
AF:
0.118
Gnomad FIN exome
AF:
0.121
Gnomad NFE exome
AF:
0.148
Gnomad OTH exome
AF:
0.177
GnomAD4 exome
AF:
0.144
AC:
194404
AN:
1350598
Hom.:
14492
Cov.:
32
AF XY:
0.144
AC XY:
95757
AN XY:
666138
show subpopulations
Gnomad4 AFR exome
AF:
0.0978
Gnomad4 AMR exome
AF:
0.147
Gnomad4 ASJ exome
AF:
0.163
Gnomad4 EAS exome
AF:
0.153
Gnomad4 SAS exome
AF:
0.116
Gnomad4 FIN exome
AF:
0.121
Gnomad4 NFE exome
AF:
0.147
Gnomad4 OTH exome
AF:
0.150
GnomAD4 genome
AF:
0.133
AC:
20272
AN:
151890
Hom.:
1408
Cov.:
32
AF XY:
0.132
AC XY:
9802
AN XY:
74268
show subpopulations
Gnomad4 AFR
AF:
0.104
Gnomad4 AMR
AF:
0.141
Gnomad4 ASJ
AF:
0.161
Gnomad4 EAS
AF:
0.123
Gnomad4 SAS
AF:
0.120
Gnomad4 FIN
AF:
0.123
Gnomad4 NFE
AF:
0.151
Gnomad4 OTH
AF:
0.148
Alfa
AF:
0.145
Hom.:
532
Bravo
AF:
0.135
TwinsUK
AF:
0.138
AC:
512
ALSPAC
AF:
0.146
AC:
563
ESP6500AA
AF:
0.0930
AC:
230
ESP6500EA
AF:
0.128
AC:
655
ExAC
AF:
0.112
AC:
2507
Asia WGS
AF:
0.113
AC:
392
AN:
3466

ClinVar

Significance: Benign
Submissions summary: Benign:13Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:10
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingGeneDxJan 05, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Mar 18, 2014- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMay 03, 2021- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJul 15, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 30% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 28. Only high quality variants are reported. -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
not provided Benign:1Other:1
not provided, no classification providedliterature onlyUniProtKB/Swiss-Prot-- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMar 11, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
22
DANN
Benign
0.91
DEOGEN2
Benign
0.031
.;.;T;.;.;.;.;.;.;T;.;.;.;T;.
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.29
FATHMM_MKL
Benign
0.43
N
LIST_S2
Benign
0.69
T;T;T;T;T;T;T;T;.;T;T;T;T;T;T
MetaRNN
Benign
0.0018
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.61
T
MutationAssessor
Benign
1.1
.;.;.;.;L;.;.;.;.;.;.;.;L;.;.
MutationTaster
Benign
0.30
P;P;P
PrimateAI
Pathogenic
0.87
D
PROVEAN
Benign
-1.7
.;N;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Benign
0.28
Sift
Uncertain
0.029
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
0.16
T;T;.;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.094
MPC
2.0
ClinPred
0.016
T
GERP RS
3.9
Varity_R
0.17
gMVP
0.52

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs16023; hg19: chr19-13409472; COSMIC: COSV64201171; API